Indication
Ulcerative colitis remission
Ulcerative colitis remission describes an inactive clinical state in pediatric and adult patients diagnosed with ulcerative colitis, a chronic inflammatory bowel disease primarily involving mucosal inflammation of the colon and rectum. Read more about Ulcerative colitis remission
60 drugs 40 manufacturers
Drugs that treat it
Common Ulcerative colitis remission therapies.
ASACOL HD (mesalamine)
DELZICOL (mesalamine)
ASACOL HD (mesalamine)
APRISO (mesalamine)
ASACOL HD (mesalamine)
SULFASALAZINE
AZULFIDINE (sulfasalazine)
AZULFIDINE (sulfasalazine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonUlcerative colitis remission describes an inactive clinical state in pediatric and adult patients diagnosed with ulcerative colitis, a chronic inflammatory bowel disease primarily involving mucosal inflammation of the colon and rectum.
As an indication and therapeutic target, remission encompasses the induction or maintenance of complete symptomatic relief—defined by the resolution of rectal bleeding and normalization of stool frequency—ideally accompanied by objective mucosal healing.
At the pathophysiologic level, this quiescent phase is characterized by the down-regulation of mucosal inflammation, endoscopic clearance of erythema, friability, and erosions, and the absence of active neutrophilic infiltration on histologic examination.
- nih.gov
Ulcerative colitis remission describes an inactive clinical state in pediatric and adult patients diagnosed with ulcerative colitis, a chronic inflammatory bowel disease primarily involving mucosal inflammation of the colon and rectum
- fda.gov
Ulcerative colitis remission describes an inactive clinical state in pediatric and adult patients diagnosed with ulcerative colitis, a chronic inflammatory bowel disease primarily involving mucosal inflammation of the colon and rectum
- romanwell.com
As an indication and therapeutic target, remission encompasses the induction or maintenance of complete symptomatic relief—defined by the resolution of rectal bleeding and normalization of stool frequency—ideally accompanied by objective mucosal healing At the pathophysiologic level, this quiescent phase is characterized by the down-regulation of mucosal inflammation, endoscopic clearance of erythema, friability, and erosions, and the absence of active neutrophilic infiltration on histologic exa...
- reddit.com
As an indication and therapeutic target, remission encompasses the induction or maintenance of complete symptomatic relief—defined by the resolution of rectal bleeding and normalization of stool frequency—ideally accompanied by objective mucosal healing At the pathophysiologic level, this quiescent phase is characterized by the down-regulation of mucosal inflammation, endoscopic clearance of erythema, friability, and erosions, and the absence of active neutrophilic infiltration on histologic exa...
- gastroendonews.com
As an indication and therapeutic target, remission encompasses the induction or maintenance of complete symptomatic relief—defined by the resolution of rectal bleeding and normalization of stool frequency—ideally accompanied by objective mucosal healing
- nih.gov
At the pathophysiologic level, this quiescent phase is characterized by the down-regulation of mucosal inflammation, endoscopic clearance of erythema, friability, and erosions, and the absence of active neutrophilic infiltration on histologic examination
Personalize your experience
Follow Ulcerative colitis remission and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.